Prime Minister Narendra Modi receives information during a visit to the Bharat Biotech facility to review the development of the Covaxin vaccine, a candidate for the indigenous COVID-19 vaccine, on the outskirts of Hyderabad, on Saturday, November 28, 2020 (Photo PTI ).
PM Modi: Focus now on developing Covid-19 vaccines
Addressing the nation on his monthly radio show Mann Ki Baat, Prime Minister Narendra Modi Sunday warned that any kind of laxity in dealing with Covid-19 is still very dangerous. He told citizens to firmly fight the ongoing pandemic and stressed that now that the national lockdown is over, the government will focus on vaccine development.
Serum Institute of India: Seeking Emergency Use License for Covid Vaccine
The Serum Institute of India (SII) said on Saturday that it is in the process of applying for an emergency use license for AstraZeneca-Oxford’s COVID-19 candidate vaccine in the next 2 weeks. At a virtual press conference on Prime Minister Narendra Modi’s visit to the company’s facilities in Pune, Serum Institute of India Executive Director Adar Poonawalla said: “We discussed the plan, the implementation plan that will be carried out. carried out only after the emergency use license, which is granted based on the data to be submitted. We are in the process of officially submitting it to the Indian drug controller … “
The vaccine will initially be distributed in India and then the company will look at Covax countries, which are mainly in Africa, he added. The Serum Institute of India (SII) is conducting clinical trials of AstraZeneca-Oxford’s COVID-19 vaccine candidate in India (with ITP).
In one of the highest seroprevalence rates reported in the country, 605 of 806 patients who underwent antibody tests in five Cuffe Parade slums tested positive for coronavirus antibodies. The Eyebetes Foundation, Dr. Nishant Kumar and BJP corporate Harshita Narwekar organized the seroprevalence survey for all residents of the district’s slums.
Conducted between October 5 and 10 in five locations in the room, the tests showed that 75% of the population tested positive for Covid antibodies, much higher than the seroprevalence results of the Brihanmumbai Municipal Corporation (BMC) of the 45% in marginal neighborhoods and 18% in buildings. .
.
